Potential Use of Interleukin-10 Blockade as a Therapeutic Strategy in Human Cutaneous Leishmaniasis

Journal of Immunology Research

Volumn 2015, Issue , 2015, Pages

  Castellano, Lucio Roberto ^a,b   Argiro, Laurent ^c   Dessein, Helia ^c   Dessein, Alain ^c   Da Silva, Marcos Vinícius ^a   Correia, Dalmo ^a   Rodrigues, Virmondes ^a  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^c Aix Marseille university   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOMODULATING AGENT; INTERLEUKIN 10; INTERLEUKIN 4; MEGLUMINE; MONOCLONAL ANTIBODY; PARASITE ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; CHEMOKINE; CYTOKINE;

ADULT; ARTICLE; ASYMPTOMATIC INFECTION; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG POTENCY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; IMMUNOTHERAPY; LEISHMANIA BRAZILIENSIS; MALE; MICROPLATE READER; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN TARGETING; SKIN LEISHMANIASIS; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; IMMUNOLOGY; LEISHMANIASIS, CUTANEOUS; METABOLISM; MONONUCLEAR CELL; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIBODIES, MONOCLONAL; CHEMOKINES; CYTOKINES; HUMANS; IMMUNOMODULATION; INTERLEUKIN-10; LEISHMANIASIS, CUTANEOUS; LEUKOCYTES, MONONUCLEAR; MALE; T-LYMPHOCYTE SUBSETS;

EID: 84944212066     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2015/152741     Document Type: Article

References (20)

1. H. W. Ghalib,M. R. Piuvezam,Y. A. W. Skeiky et al., "Interleukin 10 production correlates with pathology in human Leishmania donovani infections," Journal of Clinical Investigation, vol. 92, no. 1, pp. 324-329, 1993
2. E. Bourreau, C. Ronet, E. Darcissac et al., "Intralesional regulatory T-Cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis," Infection and Immunity, vol. 77, no. 4, pp. 1465-1474, 2009
3. A. P. Campanelli, A. M. Roselino, K. A. Cavassani et al., "CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells," Journal of Infectious Diseases, vol. 193, no. 9, pp. 1313-1322, 2006
4. L. R. Castellano, D. C. Filho, L. Argiro et al., "Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon- production," Human Immunology, vol. 70, no. 6, pp. 383-390, 2009
5. P. N. Rocha, R. P. Almeida, O. Bacellar et al., "Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis," Journal of Infectious Diseases, vol. 180, no. 5, pp. 1731-1734, 1999
6. A. Salhi, V. Rodrigues Jr., F. Santoro et al., "Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis," Journal of Immunology, vol. 180, no. 9, pp. 6139-6148, 2008
7. A. O'Garra, F. J. Barrat, A. G. Castro, A. Vicari, and C. Hawrylowicz, "Strategies for use of IL-10 or its antagonists in human disease," Immunological Reviews, vol. 223, no. 1, pp. 114-131, 2008
8. E. Bourreau, C. Ronet, P. Couppié, D. Sainte-Marie, F. Tacchini-Cottier, andP. Launois, "IL-10producingCD8+ T cells in human infection with Leishmania guyanensis," Microbes and Infection, vol. 9, no. 8, pp. 1034-1041, 2007
9. S. Gautam, R. Kumar, R. Maurya et al., "IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis," Journal of Infectious Diseases, vol. 204, no. 7, pp. 1134-1137, 2011
10. C. D. S. Santos, V. Boaventura, C. Ribeiro Cardoso et al., "CD8+ granzyme B+-mediated tissue injury vs. CD4+ IFN +-mediated parasite killing in human cutaneous leishmaniasis," Journal of Investigative Dermatology, vol. 133, no. 6, pp. 1533-1540, 2013
11. F. O. Novais, L. P. Carvalho, J. W. Graff et al., "Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis," PLoS Pathogens, vol. 9, no. 7,Article ID e1003504, 2013
12. M. Cabrera, M.-A. Shaw, C. Sharples et al., "Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis," Journal of Experimental Medicine, vol. 182, no. 5, pp. 1259-1264, 1995
13. O. Bacellar, H. Lessa, A. Schriefer et al., "Up-regulation of Th1-type responses inmucosal leishmaniasis patients," Infection and Immunity, vol. 70, no. 12, pp. 6734-6740, 2002
14. W. N. Oliveira, L. E. Ribeiro, A. Schrieffer, P. Machado, E. M. Carvalho, and O. Bacellar, "The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis," Cytokine, vol. 66,no. 2, pp. 127-132, 2014
15. D. R. Faria, K. J. Gollob, J. Barbosa Jr. et al., "Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis," Infection and Immunity, vol. 73, no. 12, pp. 7853-7859, 2005
16. E. M. Carvalho, W. D. Johnson, E. Barreto et al., "Cell mediated immunity in American cutaneous and mucosal leishmaniasis," Journal of Immunology, vol. 135, no. 6, pp. 4144-4148, 1985
17. R. Badaro, E. Falcoff, F. S. Badaro et al., "Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma," The New England Journal of Medicine, vol. 322, no. 1, pp. 16-21, 1990
18. S. Sundar, F. Rosenkaimer, M. L. Lesser, and H. W. Murray, "Immunochemotherapy for a systemic intracellular infection: accelerated response using interferon-gamma in visceral leishmaniasis," Journal of Infectious Diseases, vol. 171, no. 4, pp. 992-996, 1995
19. O. P. Singh and S. Sundar, "Immunotherapy and targeted therapies in treatment of visceral leishmaniasis: current status and future prospects," Frontiers in Immunology, vol. 5, article 296, 2014
20. W. Mayrink, A. C. de Carvalho Botelho, P. A. Magalhães et al., "Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment," Revista da Sociedade Brasileira de Medicina Tropical, vol. 39, no. 1, pp. 14-21, 2006.